Septerna, Inc. Common Stock share price logo

Septerna, Inc. Common Stock

NASDAQ: SEPN

Small Cap

$31.18

-0.19

(-0.61%)

as on

Septerna, Inc. Common Stock Stock Performance

as on June 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $30.47
    $31.41
    downward going graph

    2.28%

    Downside

    0.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $9.70
    $32.63
    downward going graph

    68.89%

    Downside

    4.65%

    Upside

    downward going graph

Septerna, Inc. Common Stock share price movements today

Previous Close
$31.37
Open
$31.05
Volume
628.7K
Day's Low - High
$30.47 - $31.41
52 Week Low - High
$9.70 - $32.63

Septerna, Inc. Common Stock Historical Returns

1 Month Return
+ 30 %
3 Month Return
+ 14.2 %
1 Year Return
+ 198.19 %
3 Year Return
0 %
5 Year Return
0 %

Septerna, Inc. Common Stock Stock Fundamentals & Key Indicators

Check Septerna, Inc. Common Stock market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.4B

EPS (TTM)

-1.839

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

Return On Equity TTM

-9.26%

Septerna, Inc. Common Stock vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Septerna, Inc. Common Stock with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Septerna, Inc. Common Stock image
Septerna, Inc. Common Stock
NA$1.4BNANA-49.88%NA
Revolution Medicines Inc image
Revolution Medicines Inc
BUY$32.2B410.63%NA0.00%NA
Alnylam Pharmaceuticals Inc image
Alnylam Pharmaceuticals Inc
BUY$39.1B108.54%73.5112.55%NA
Vertex Pharmaceuticals Inc image
Vertex Pharmaceuticals Inc
BUY$108.7B110.42%25.4535.51%NA
Regeneron Pharmaceuticals Inc image
Regeneron Pharmaceuticals Inc
BUY$64.9B22.83%15.1129.65%0.59%

Stock Returns calculator for Septerna, Inc. Common Stock Stock including INR - Dollar returns

The Septerna, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Septerna, Inc. Common Stock investment value today

Current value as on today

₹3,27,810

Returns

₹2,27,810

(+227.81%)

Returns from Septerna, Inc. Common Stock Stock

₹1,96,388 (+196.39%)

Dollar Impact

₹31,422 (+31.42%)

Indian Investors' Interest in Septerna, Inc. Common Stock Stock

Search interest for Septerna, Inc. Common Stock Stock has increased by 88% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:88% versus previous 30 day period

Septerna, Inc. Common Stock Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
21
24
26
Gross Profit
0
0
0
0
0
0
0
21
24
26
Operating Income
34
-15
-18
-22
-24
-25
-28
2
-16
-13
EBITDA
-13
-15
-17
-22
-24
-25
-28
-9
-15
-12
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
35
-14
-16
-20
-20
-21
-24
8
-10
-8
Income Tax Expense
0
0
0
0
0
-
-
-
0
0
Net Income
34
-14
-16
-20
-20
-21
-24
8
-10
-8
Net Profit Margin
29571.19%
-4468.77%
-4443.51%
-11660.80%
-9749.06%
-9806.39%
-20872.27%
38.02%
-44.52%
-32.56%

Septerna, Inc. Common Stock Annual Profit & Loss

All numbers in Millions USD

Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
1
45
Gross Profit
-
0
1
45
Operating Income
-27
2
-80
-80
EBITDA
-27
-44
-79
-79
Interest Expense
-
-
-
-
Depreciation
0
0
1
1
Income Before Tax
-27
4
-72
-48
Income Tax Expense
-
0
0
0
Net Income
-27
4
-71
-48
Net Profit Margin
0.00%
2768.21%
-6678.88%
-106.37%

Septerna, Inc. Common Stock Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-14
-16
-20
-20
-21
-24
8
-10
-8
Operating Cash Flow
-16
-12
-16
-20
-23
-20
168
-14
-25
Investing Cash Flow
9
-12
-24
-133
-4
0
-38
-185
-23
Financing Cash Flow
-
74
-1
304
0
0
0
1
0
Change in Cash
-7
131
-42
149
-28
-20
130
-199
-49

Septerna, Inc. Common Stock Annual Cash Flow

All numbers in Millions USD

Dec 2023
Dec 2024
Dec 2025
Net Income
4
-71
-48
Operating Cash Flow
-38
-67
110
Investing Cash Flow
22
-160
-229
Financing Cash Flow
74
377
1
Change in Cash
57
149
-117

Global Institutional Holdings in Septerna, Inc. Common Stock

Funds
Holdings
The Goldman Sachs Group Inc
6.47%
Siren, L.L.C.
4.45%
Casdin Capital, LLC
1.23%
Driehaus Capital Management LLC
9.78%
Samsara BioCapital, LLC
7.01%
See all

Insights on Septerna, Inc. Common Stock

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SEPN stock has moved up by 30.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 287.3% return, outperforming this stock by 89.1%

About Septerna, Inc. Common Stock

Septerna, Inc., a clinical-stage biotechnology company, discovers and develops G protein-coupled receptor (GPCR) oral small molecule products for the treatment of endocrinology, immunology and inflammation, and metabolic diseases. It develops PTH1R Program, oral small molecule Parathyroid Hormone 1 Receptor agonists for the treatment of hypoparathyroidism; SEP-631, an oral small molecule MRGPRX2 negative allosteric modulator (NAM) for chronic spontaneous urticaria and other mast cell diseases; and TSHR Program, an oral small molecule TSHR NAM for graves' disease and thyroid eye disease. In addition, it focuses on other therapeutic areas, including neurology, women's health, cardiovascular disease, and respiratory disease. It has global collaboration and license agreement with Novo Nordisk to discover, develop and commercialize multiple potential oral small molecule therapies for metabolic-related diseases based on certain specified molecular targets. The company was formerly known as GPCR NewCo, Inc. and changed its name to Septerna Inc. in June 2021. Septerna, Inc. was incorporated in 2019 and is headquartered in South San Francisco, California.
OrganisationSepterna, Inc. Common Stock
Headquarters250 East Grand Avenue, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEODr. Jeffrey T. Finer M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Septerna, Inc. Common Stock

Name

Title

Mr. Richard Hansen Ph.D.

Vice President of Technology

Mr. Mark A. Wilson J.D.

Chief Legal Officer

Ms. Samira Shaikhly

Chief People Officer

Dr. Jeffrey T. Finer M.D., Ph.D.

Co-Founder, CEO & Director

Ms. Elizabeth P. Bhatt M.B.A., M.S.

President & COO

Dr. Arthur Christopoulos BPHARM, Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Dr. Patrick Sexton Ph.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Mr. Gilbert M. Labrucherie C.F.A., J.D.

Chief Financial Officer

Dr. Robert J. Lefkowitz M.D.

Co-Founder and Member of Cross-Functional Scientific & Drug Discovery Advisory Board

Mr. George Xu Ph.D.

Senior Director of Corporate Development & Portfolio Strategy

FAQs

What is Septerna, Inc. Common Stock share price today?

Septerna, Inc. Common Stock share price today is $31.18 as on at the close of the market. Septerna, Inc. Common Stock share today touched a day high of $31.41 and a low of $30.47.

What is the 52 week high and 52 week low for Septerna, Inc. Common Stock share?

Septerna, Inc. Common Stock share touched a 52 week high of $32.63 on and a 52 week low of $9.7 on . Septerna, Inc. Common Stock stock price today i.e. is closed at $31.18,which is 4.44% down from its 52 week high and 221.44% up from its 52 week low.

What is Septerna, Inc. Common Stock's market capitalisation today?

Septerna, Inc. Common Stock market capitalisation is $0.00T as on .

How to invest in Septerna, Inc. Common Stock Stock (SEPN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Septerna, Inc. Common Stock on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Septerna, Inc. Common Stock Shares that will get you 0.0481 shares as per Septerna, Inc. Common Stock share price of $31.18 per share as on June 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Septerna, Inc. Common Stock Stock (SEPN) from India?

Indian investors can start investing in Septerna, Inc. Common Stock (SEPN) shares with as little as ₹94.935 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.35 in Septerna, Inc. Common Stock stock (as per the Rupee-Dollar exchange rate as on ). Based on Septerna, Inc. Common Stock share’s latest price of $31.18 as on June 6, 2026 at 1:29 am IST, you will get 0.3207 shares of Septerna, Inc. Common Stock. Learn more about fractional shares .